| Literature DB >> 30609834 |
Anthony R Mawson1, Ashley M Croft2.
Abstract
An estimated 25%⁻32% of veterans of the 1991 Gulf War continue to experience multiple unexplained health problems known as Gulf War Illness (GWI). GWI encompasses chronic pain, musculoskeletal weakness, headache, fatigue, cognitive deficits, alterations in mood, and numerous multi-system complaints. Most potential exposures implicated in GWI were not well documented but included varying levels of several neurotoxicants as well as the anticholinergic drug pyridostigmine bromide (PB), which was routinely taken as prophylaxis against the nerve agent soman. While some veterans also took chloroquine as an antimalarial agent, the literature suggests an association between receipt of multiple vaccinations prior to or during the conflict (perhaps combined with other exposures), and GWI. In-theater exposures may account for any single individual veteran's ill health but many veterans of the same era who were not deployed overseas also suffer the same or similar symptoms. The features of GWI also overlap with those of fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity, in all of which liver dysfunction has been documented, suggesting a unifying hypothesis. It is proposed that multiple vaccinations, with concurrent or subsequent exposure to PB or additional chemical insults of a liver-damaging nature, plausibly explain the pathogenesis and the observed chronicity of GWI. The suggested mechanism for GWI is thus a chemically-induced impaired liver function, with the spillage of stored vitamin A compounds ("retinoids") into the circulation in toxic concentrations, resulting in an endogenous chronic form of hypervitaminosis A. Implications of the hypothesis are briefly reviewed.Entities:
Keywords: Gulf War Illness; chemicals; cognition; exposures; fatigue; headache; musculoskeletal pain; pathogenesis; retinoids; risk factors; vaccines; veterans
Mesh:
Substances:
Year: 2019 PMID: 30609834 PMCID: PMC6339135 DOI: 10.3390/ijerph16010111
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Medical conditions associated with Gulf War Illness.
| Condition | GW Veterans vs. Gulf Era Veterans (% Difference) | Adjusted Odds Ratio and 95% Confidence Interval |
|---|---|---|
| Chronic multisymptom illness | 43.9% vs. 20.3% | 2.36; 1.94, 2.86 |
| Chronic fatigue syndrome | 11.8% vs. 5.3% | 2.36; 1.94, 2.86 |
| Neuralgia | 9.4% vs. 6.3% | 1.65; 1.40, 1.95 |
| Gastritis | 20.2% vs. 14.3% | 1.59; 1.35, 1.73 |
| Chronic obstructive pulmonary disease | 8.4% vs. 6.3% | 1.48; 1.23, 1.78 |
| Fibromyalgia | 3.7% vs. 2.9% | 1.48; 1.15, 1.91 |
| Tachycardia | 8.1% vs. 5.9% | 1.47; 1.20, 1.79 |
| Dermatitis | 27.4% vs. 21.1% | 1.44; 1.27, 1.63 |
| Rheumatoid arthritis | 9.9% vs. 7.9% | 1.40; 1.17, 1.67 |
| Seizures | 2.7% vs. 2.0% | 1.38; 1.03, 1.85 |
| Coronary heart disease | 5.6% vs. 5.3% | 1.32; 1.09, 1.59 |
| Migraine headaches | 20.3% vs. 16.1% | 1.30; 1.15, 1.47 |
| Hypertension | 43.0% vs. 40.0% | 1.22; 1.10, 1.35 |
| Asthma | 10.2% vs. 9.0% | 1.22; 1.04, 1.44 |
| Unspecified arthritis | 33.9% vs. 31.8% | 1.16; 1.05, 1.29 |
| Irritable bowel syndrome | 24.4% vs. 14.3% | 2.10; 1.79, 2.45 |
| Functional dyspepsia: | 27.7% vs. 15.9% | 1.94; 1.75, 2.17 |
| PTSD in the past 4 weeks | 20.9% vs. 11.5% | 1.93; 1.67, 2.24 |
| Major depressive disorder, past 2 weeks | 32.9% vs. 22.9% | 1.56; 1.41, 1.73 |
| Other depressive disorder, past 2 weeks | 23.5% vs. 19.1% | 1.24; 1.08, 1.38 |
| Other anxiety disorder, past 4 weeks | 18.7% vs. 14.4% | 1.34; 1.17, 1.54 |
| Somatic symptom severity, past 4 weeks | 16.1% vs. 8.3% | 2.10; 1.79, 2.45 |
Source: Ref. [7].
U.S. Military Personnel Directed to Receive Vaccine Schedule at the time of the Gulf War.
| Vaccine | Military Personnel | Schedule/Dose |
|---|---|---|
| Adenovirus | All recruits | 1 oral dose |
| Influenza | All recruits and active duty | Annual shot |
| Measles | All recruits | 1 shot |
| Meningococcal | All recruits, active duty as required | 1st shot, then booster every 3–5 years |
| Plague | All Marines; Army and Navy special forces, others in at-risk occupations or deploying to high risk areas | 5 shots over 12 months, then booster every 1–2 years |
| Polio | All recruits | 1 oral dose |
| Rabies | Special forces, at-risk occupations | 3 shot series |
| Rubella | All recruits | 1 shot |
| Smallpox vaccine or booster | New recruits through the late 1980s | 1 dose |
| Tetanus-diphtheria | All recruits, active duty, and reserve | Booster every 10 years |
| Typhoid | Army and Air Force alert forces and for deployment to high risk areas | 2 doses in 2 months, then booster every 3 years |
| Yellow fever | All Navy and Marine Corps, Army and Air Force alert forces and for deployment to high risk areas | 1st shot, then booster every 10 years |
Source: Ref. [9].
Figure 1Retinoid toxicity hypothesis of Gulf War Illness.
Figure 2Metabolism of Vitamin A.
Similarities between the signs and symptoms of Gulf War Illness and of chronic hypervitaminosis A.
| Major Signs/Symptoms | Gulf War Illness | Chronic Hypervitaminosis A |
|---|---|---|
| Mood swings, irritability | + | + |
| Memory loss, lack of concentration | + | + |
| Anxiety, stress, sleep disturbance | + | + |
| Depression | + | + |
| Other psychiatric disorders | + | + |
| Muscular pain, weakness | + | + |
| General Fatigue | + | + |
| Fevers/Night sweats | + | + |
| Headaches | + | + |
| Numbness, tingling, dizziness | + | + |
| Sinus congestion | + | + |
| Chronic, frequent infection | + | + |
| Skin allergies, other allergies | + | + |
| Respiratory problems | + | + |
| Digestive, stomach and intestinal disorders | + | + |
| Weight gain/loss | + | + |
| Reproductive disorders | + | + |
Sources: GWI: [9,38,39,40]; Chronic hypervitaminosis A: [31,41,42,43].